Contains clarification and instructions for therapeutic substitution of selected medications and explains P&T authorities for therapeutic substitution

Provides recommendations of the P&T Committee on formulary inclusion of new drugs, drug class reviews, conclusions from utilization management, and final votes

Provides P&T committee recommendations for formulary inclusion of new drugs, drug class reviews, utilization management conclusions, and final votes

Clarifies and outlines the process of therapeutic substitution of selected agents and establishes the authority of the P&T Committee in this endeavor

Provides P&T committee recommendations for formulary inclusion of new drugs, drug class reviews, conclusions from utilization management and final votes

Contains recommendations from the P&T committee meeting and proceedings from the BAP panel outlining votes and final actions

Details recommendations and decisions made by P&T Committee and the proceedings of the BAP panel surrounding these recommendations as well as final votes and actions

Details recommendations and decisions from the P&T committee meeting and the votes and discussion surrounding these recommendations by the BAP panel

Most recent version of the Specialty Drug list.

Most recent Maintenance Drug List.

Most recent Tier4/Not Covered Drug List.

Most recent Prior Authorization Medication List.

Most recent non-formulary drug list.

Most recent Basic/Extended Core Formulary document.

Contains summary of P&T committee proceedings, recommendations and conclusions from May 2026